MAPT and Alzheimer disease: By lowering the amounts of soluble hippocampus Aβ1–42, presenilin 1 protein, and phosphorylated tau, Bifidobacterium breve MCC1274 supplementation in wild-type (WT) mice reduced the AD-related pathologies.